GH1 and hepatocellular carcinoma: Disruption of the GH/JAK2/STAT5 signaling pathway, a result of inhibited growth hormone (GH) secretion (brought on by obesity, inflammation, and excessive glucose), results in increased lipid accumulation in the liver, further leading to MAFLD and subsequently HCC (108).